Floatz logo

Eicosapentanoic Acid

Cardiovascular Diseases

UConn HealthPhase 2/3Dormant
CCC
55/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
81/ 100

Competitive context

35 Active assets in the Cardiovascular Diseases cohort.

Asset / SponsorPhaseRating
Acetylsalicylic Acid
University of Roma La Sapienza
Phase 4BB
WARFARIN
Seoul National University Hospital
Phase 4BB
Rivaroxaban
China National Center for Cardiovascular Diseases
Phase 4BB
Dolutegravir
Thomas Benfield
Phase 4BB
CITALOPRAM
Ege University
Phase 4BB

View all 50 →

Same molecule, other indications

Eicosapentanoic Acid is also rated in:

major depressive disorderDormant
BB
Indicative ·
68 / 100
View asset →
drug-induced dyskinesiaDormant
BB
Indicative ·
68 / 100
View asset →
ProdromeDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →